Evidence map›Paper›PMID 34523254›Full record

ArticleESC heart failure2021

Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department.

Davor Milicic, Binyamin Ben Avraham, Ovidiu Chioncel, Yaron D Barac, Eva Goncalvesova, Avishai Grupper, Johann Altenberger, Maria Frigeiro, Arsen Ristic, Nicolaas De Jonge and 31 more

Erratum issuedOpen access · goldAbstract readConsensus Statement
In one paragraph

Article in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Corrigendum.ESC heart failure · 2022
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 22 countries.

Davor MilicicDepartment for Cardiovascular Diseases, Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia.
Binyamin Ben AvrahamHeart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ovidiu ChioncelEmergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.
Yaron D BaracDepartment of Cardiothoracic Surgery, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eva GoncalvesovaOdd. Srdcovehozlyhavania a Transplantacie, Bratislava, Slovakia.
Avishai GrupperHeart Failure Institute, Lev Leviev Heart Center, Chaim Sheba Medical Center, Tel HaShomer, Israel.
Johann AltenbergerSKA-Rehabilitationszentrum Großgmain, Großgmain, Austria.
Maria FrigeiroTransplant Center and De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
Arsen RisticDepartment of Cardiology of the Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia.
Nicolaas De JongeDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Steven TsuiTransplant Unit, Royal Papworth Hospital, Cambridge, UK.
Jacob LaveeSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Giuseppe RosanoCentre for Clinical and Basic Research, Department of Cardiac & Pulmonary Rehabilitation Sciences, IRCCS San Raffaele Pisana, Rome, Italy.
Marisa Generosa Crespo-LeiroComplexo Hospitalario Universitario A Coruña (CHUAC), CIBERCV, Instituto de Investigacion Biomedica A Coruña (INIBIC), Universidade da Coruña (UDC), A Coruña, Spain.
Andrew J S CoatsFaculty of Medicine, University of Warwick, Coventry, UK.
Petar SeferovicSerbian Academy of Sciences and Arts, Heart Failure Center, Faculty of Medicine, Belgrade University Medical Center, Belgrade, Serbia.
Frank RuschitzkaDepartment of Cardiology, University Hospital, University Heart Center, Zürich, Switzerland.
Marco MetraCardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Stefan AnkerDepartment of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Berlin, Germany.
Gerasimos FilippatosHeart Failure Unit, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Stamatis AdamopoulosHeart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Miriam AbuhaziraDepartment of Cardiothoracic Surgery, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Jeremy EllistonAnesthesiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Israel GotsmanHeart Institute, Hadassah University Hospital, Jerusalem, Israel.
Righab HamdanDepartment of Cardiology, Beirut Cardiac Institute, Beirut, Lebanon.
Yoav HammerHeart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tal HasinJesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel.
Lorrena HillSchool of Nursing and Midwifery, Queen's University, Belfast, UK.
Osnat Itzhaki Ben ZadokHeart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Wilfried MullensZiekenhuis Oost-Limburg, Genk, Belgium.
Sanemn NalbantgilDepartment of Cardiology, Ege University Hospital, İzmir, Turkey.
Massimo Francesco PiepoliHeart Failure Unit, Cardiology, G. da Saliceto Hospital, Piacenza, Italy.
Piotr PonikowskiCentre for Heart Diseases, University Hospital, Wrocław, Poland.
Luciano PotenaHeart and Lung Transplant Program, Bologna University Hospital, Bologna, Italy.
Arjang RuhparwarDepartment of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany.
Aviv ShaulHeart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laurens F TopsDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Stephan WinnikDepartment of Cardiology, University Heart Center, University Hospital Zürich, Zürich, Switzerland.
Tiny JaarsmaDepartment of Nursing, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Finn GustafssonDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Tuvia Ben GalHeart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rabin Medical Center · ILSheba Medical Center · ILTel Aviv University · ILArt Research Centre of the Slovak Academy of Sciences · SKAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITBerlin-Brandenburger Centrum für Regenerative Therapien · DECarol Davila University of Medicine and Pharmacy · ROCentar za Promociju Nauke · RSEge University · TRFZI Research Center for Information Technology · DEGNA University · INGuglielmo da Saliceto Hospital · ITHadassah Academic College · ILHasselt University · BEHeidelberg University · USIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleLeiden University Medical Center · NLLinköping University · SENational and Kapodistrian University of Athens · GROnassis Cardiac Surgery Center · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD-supported patients and the probability of those patients to present to the emergency department with expected and non-expected device-related and patient-device interaction complications. The ageing of the LVAD-supported patients, mainly those supported with the 'destination therapy' indication, increases the risk for those patients to suffer from other co-morbidities common in the older population. In this second part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, definitions and structured approach to the LVAD-supported patient presenting to the emergency department with bleeding, neurological event, pump thrombosis, chest pain, syncope, and other events are presented. The very challenging issue of declaring death in an LVAD-supported patient, as the circulation is artificially preserved by the device despite no other signs of life, is also discussed in detail.

Indexed as

CardiologyHeart-Assist DevicesHeart FailureHeart TransplantationEmergency Service, HospitalHealth PersonnelHumansTissue DonorsBleedingDeath declarationEmergency departmentLVADNeurological events

Identifiers

PMID34523254
PMCPMC8712806
OpenAlexW3200174867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.